BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21115901)

  • 1. Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.
    Lui VC; Lung SS; Pu JK; Hung KN; Leung GK
    Anticancer Res; 2010 Nov; 30(11):4515-24. PubMed ID: 21115901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
    Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
    Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of TFPI-2 promotes migration and invasion of glioma cells.
    Gessler F; Voss V; Seifert V; Gerlach R; Kögel D
    Neurosci Lett; 2011 Jun; 497(1):49-54. PubMed ID: 21530612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
    Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
    Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
    Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
    Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
    Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
    J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion.
    Luk SK; Piekorz RP; Nürnberg B; Tony To SS
    Eur J Cancer; 2012 Jan; 48(1):149-57. PubMed ID: 22079609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of annexin 2 decreases migration of human glioma cells in vitro.
    Tatenhorst L; Rescher U; Gerke V; Paulus W
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
    Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
    Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific isoform of glial cell line-derived neurotrophic factor family receptor alpha 1 regulates RhoA expression and glioma cell migration.
    Wan G; Too HP
    J Neurochem; 2010 Nov; 115(3):759-70. PubMed ID: 20807316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
    Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
    Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture.
    An Z; Gluck CB; Choy ML; Kaufman LJ
    Cancer Lett; 2010 Jun; 292(2):215-27. PubMed ID: 20060208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.